N@N

BioScrip, Inc. to Present at the 22nd Annual Piper Jaffray Health Care Conference

^{Published on 2010-11-17 14:15:42 - Market Wire}
 

ELMSFORD, N.Y.--([ BUSINESS WIRE ])--BioScrip, Inc. (Nasdaq: BIOS) today announced that it will present at the 22^nd Annual Piper Jaffray Health Care Conference to be held on Tuesday, November 30 a" Wednesday, December 1 at The New York Palace Hotel in New York City.

Richard M. Smith, President and Chief Operating Officer, and Phillip J. Keller, Senior Vice President and Principal Accounting Officer, are scheduled to present on Wednesday, December 1, 2010 at 9:30 AM Eastern Standard Time. A live audio webcast of the event may be accessed at Webcast URL: [ http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=BIOS&item_id=3494794 ].

A replay of the presentation will be available through BioScripa™s website at [ www.bioscrip.com ] under the aInvestor Relationsa Section and will remain available through Wednesday, December 15, 2010.

About BioScrip, Inc.

BioScrip, Inc. ([ www.bioscrip.com ]) (Nasdaq: BIOS) is a national provider of specialty pharmacy and home care products and services that partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and delivery of cost-effective access to prescription medications. Our services are designed to improve clinical outcomes for chronic and acute healthcare conditions while controlling overall healthcare costs.

Forward Looking Statements a" Safe Harbor

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.